Radiotherapy for nonagenarians: the value of biological versus chronological age
Abstract Background The number of nonagenarian cancer patients (≥ 90 years) is continuously increasing, and radiotherapy is performed in a relevant proportion of patients, as surgery and chemotherapy are often not feasible for these patients. However, the evidence regarding the feasibility and treat...
Main Authors: | Tanja Sprave, Alexander Rühle, Raluca Stoian, Alina Weber, Constantinos Zamboglou, Carsten Nieder, Anca-Ligia Grosu, Nils H. Nicolay |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01563-x |
Similar Items
-
Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?
by: Alexander Rühle, et al.
Published: (2021-03-01) -
The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly
by: Erik Haehl, et al.
Published: (2021-06-01) -
Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
by: Erik Haehl, et al.
Published: (2020-02-01) -
Readmission of older acutely admitted medical patients after short-term admissions in Denmark: a nationwide cohort study
by: M. Klinge, et al.
Published: (2020-06-01) -
The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers
by: Alexander Rühle, et al.
Published: (2020-06-01)